SCHEMBL14560417

SCHEMBL14560417

CCCCN1C(=O)C(c2ccccc2)C(c2ccccc2)C1=O

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 7/20 0.55
CNR1 P21554 1/20 0.55
SMN1; SMN2 Q16637 2/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
LMNA P02545 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
ALDH1A1 P00352 2/20 0.43
HSD17B10 Q99714 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CYP19A1 P11511 1/20 0.43
CDC25A P30304 1/20 0.43
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14560424 0.93 CNR2 (0.65) CNR2CNR1ALDH1A1CYP19A1CDC25A
SCHEMBL14560505 0.81 CNR2 (0.48) CNR2CNR1SMN1; SMN2NPC1RAB9A
SCHEMBL14560421 0.78 MAPT (0.48) CNR2CNR1SMN1; SMN2LMNAADORA3
SCHEMBL14560604 0.77 CNR2 (0.88) CNR2CNR1SMN1; SMN2LMNAMEN1
SCHEMBL11459127 0.77 LMNA (0.71) CNR2CNR1SMN1; SMN2NPC1RAB9A
SCHEMBL14560410 0.76 CYP19A1 (0.74) CNR2CNR1SMN1; SMN2MEN1KMT2A
SCHEMBL14560487 0.75 ADRA1D (0.56) SMN1; SMN2MEN1KMT2AALDH1A1CYP19A1
SCHEMBL18665510 0.74 SMN1; SMN2 (0.50) CNR2CNR1SMN1; SMN2NPC1RAB9A
SCHEMBL21537191 0.74 CNR2 (0.44) CNR2CNR1SMN1; SMN2NPC1RAB9A
SCHEMBL14560485 0.73 CYP19A1 (0.56) CNR2CNR1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7192967-B1 Cyclic imide-substituted pyridylalkane, alkene, alkine carboxamides useful as cytostatic and immunosuppressive agents ASTELLAS PHARMA GMBH (DE) 2007-03-20 US disclosed